A quantitative circulating single-molecule amplification and resequencing technology cSMART assay was developed for the non-invasive prenatal diagnosis (NIPD) of autosomal recessive non-syndromic HL caused by GJB2 and SLC26A4 pathogenic variants [27]. This evidence concerns the gene GJB2 and Hodgkins lymphoma.